Bank Julius Baer & Co
BIO icon

Bank Julius Baer & Co’s Bio-Rad Laboratories Class A BIO Stock Holding History

Bank Julius Baer & Co’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-217
Closed -$107K – 578
2022
Q2 		$107K Hold
217
– – ﹤0.01% 479
2022
Q1 		$122K Hold
217
– – ﹤0.01% 472
2021
Q4 		$164K Sell
217
-1,518
-87% -$1.14M ﹤0.01% 561
2021
Q3 		$1.29M Buy
1,735
+641
+59% +$480K 0.01% 300
2021
Q2 		$705K Buy
1,094
+818
+296% +$498K ﹤0.01% 402
2021
Q1 		$158K Sell
276
-1,570
-85% -$930K ﹤0.01% 573
2020
Q4 		$1.08M Buy
1,846
+737
+66% +$420K 0.01% 343
2020
Q3 		$572K Buy
1,109
+973
+715% +$493K 0.01% 365
2020
Q2 		$61K Buy
+136
New +$60K ﹤0.01% 554

Other funds holding BIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
VAM
Veritas Asset Management London, United Kingdom $5.9B AUM 3.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return